Displaying drugs 4526 - 4550 of 6481 in total
2,5-Diaminopyrimidin-4,6-diol
Experimental
D-galactohydroximo-1,5-lactam
Experimental
S-Nitrosoglutathione
Investigational
ENA-001
Investigational
Methyl 2,5-dihydroxycinnamate
Experimental
3,4,5-Trimethoxyamphetamine
Experimental
Illicit
1-Ethyl-Pyrrolidine-2,5-Dione
Experimental
4,5-Dehydro-D-Glucuronic Acid
Experimental
D-gluconhydroximo-1,5-lactam
Experimental
Inositol 2,4,5-trisphosphate
Experimental
Belagenpumatucel-L (NCI H-520)
Investigational
NRC-AN-019
Investigational
Exbivirumab
Exbivirumab is an investigational monoclonal antibody. It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies to the hepatitis B virus (HBV) surface antigen.
Investigational
Azenosertib
Investigational
AUM-302
Investigational
Mavorixafor
Mavorixafor is a small molecule drug candidate that belongs to a new investigational class of anti-HIV drugs known as entry (fusion) inhibitors. Currently there is only one FDA-approved entry inhibitor, enfuvirtide (Fuzeon), that is available for the treatment of HIV infection. Several experimental entry inhibitors are now in early stage...
Investigational
3-Dehydroshikimate
Experimental
1alpha-Hydroxyvitamin D5
1alpha-Hydroxyvitamin D5 (CARD-024) has been used in trials studying the treatment of Drug Safety and Heart; Disease, Activity.
Investigational
Matched Iupac: … (1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden …
Modakafusp alfa
Modakafusp alfa is under investigation in clinical trial NCT03215030 (A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-573 in Participants With Refractory Multiple Myeloma (MM)).
Investigational
PBR-06 F-18
Investigational
Displaying drugs 4526 - 4550 of 6481 in total